![Liora Sklair-Tavron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Liora Sklair-Tavron was previously employed as a Chief Operating Officer by Regentis Biomaterials Ltd. and a Director-Regulatory Affairs by Bioblast Pharma Ltd. She received her doctorate degree from Weizmann Institute of Science.
Anciens postes connus de Liora Sklair-Tavron
| Sociétés | Poste | Fin |
|---|---|---|
| REGENTIS BIOMATERIALS LTD. | Directeur des opérations | 01/01/2019 |
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Conseiller Juridique Général | - |
Formation de Liora Sklair-Tavron
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regentis Biomaterials Ltd.
 Regentis Biomaterials Ltd. BiotechnologyHealth Technology Develops proprietary hydrogels for tissue regeneration | Health Technology |
